A complete application in a minute
Tailored resume and cover letter, ready to send.
Johnson & Johnson's Janssen CAR-T Europe hub in Ghent, Belgium seeks a QA Qualification Manager to oversee qualification across CAR-T manufacturing units. You will ensure regulatory compliance, lifecycle management of facilities and equipment, and QA support for expansion projects.
The role requires a senior QA professional with strong leadership, risk-based thinking, and the ability to interact with cross-functional teams and regulatory bodies in a dynamic biopharma setting.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com .
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Quality
Quality Assurance
Professional
Gent, East Flanders, Belgium
Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.
Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.
Learn more at https://www.jnj.com/innovative-medicine
Janssen Pharmaceutica is recruiting a QA Qualification Manager, CAR-T EMEA
Johnson & Johnson EMEA CAR-T is recruiting a QA Qualification Manager for its European CAR-T manufacturing hub, based in Ghent, Belgium.
CAR-T (chimeric antigen receptor T-cell) therapy is an innovative treatment approach that harnesses a patient's own immune system. A patient's T cells are genetically engineered to recognise and eliminate cancer cells expressing a specific antigen.
To support the CAR-T programme in EMEA, J&J has established two CAR-T manufacturing centres in the Ghent area, Belgium. Quality Control laboratories operate from the existing J&J site in Beerse.
The QA Qualification Manager, CAR-T Europe, is accountable for providing quality oversight and ensuring the compliant qualification and lifecycle management of facilities, utilities and production equipment across the CAR-T manufacturing units.